Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalls Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (U…

Recall date

December 6, 2022

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0181-2023

FDA classification

Class I

Brand / firm

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Sold / distributed

Nationwide in the USA.

Why it was recalled

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940